日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Safety and immunogenicity of SARS-CoV-2 protein subunit recombinant vaccine (Indovac®) in healthy populations aged 18 years and above in Indonesia: A phase I, observer-blind, randomized, controlled study

在印度尼西亚18岁及以上健康人群中，SARS-CoV-2蛋白亚单位重组疫苗（Indovac®）的安全性和免疫原性：一项I期、观察者盲法、随机、对照研究

期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2025.2501467
Nency, Yetty Movieta; Sekartini, Rini; Wirahmadi, Angga; Maria, Suzy; Farhanah, Nur; Hapsari, Rebriarina; Mahati, Endang; Maharani, Nani; Mulyono, Mulyono; Anantyo, Dimas Tri; Pramudo, Setyo Gundi; Yeremia, Glenn Fernandez; Setyaningsih, Lilis; Puspita, Mita; Sari, Rini Mulia
SARS-CoV-2
免疫/内分泌
发表日期：2025
文献求助 收藏

Urinary detection of high-risk HPV DNA to enhance cervical cancer screening in developing countries

利用尿液检测高危型HPV DNA来加强发展中国家的宫颈癌筛查

期刊:Microbiology Spectrum
影响因子:
doi:10.1128/spectrum.01938-24
Intan, Novia Syari; Utama, Revata; Wulandari, Dewi; Wisdharilla, Reiva; Khanza, Shafira Mutia; Ramadhan, Muhamad Rifki; Widyahening, Indah Suci; Nurainy, Neni; Sari, Rini Mulia; Andrijono
宫颈癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Immunogenicity and Safety of SARS-CoV-2 Protein Subunit Recombinant Vaccine (IndoVac(®)) as a Heterologous Booster Dose against COVID-19 in Indonesian Adolescents

SARS-CoV-2 蛋白亚单位重组疫苗（IndoVac®）作为异源加强剂在印尼青少年中对抗 COVID-19 的免疫原性和安全性

期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines12080938
Fadlyana, Eddy; Rusmil, Kusnandi; Dwi Putra, Muhammad Gilang; Fulendry, Frizka Primadewi; Somantri, Nitta Kurniati; Putri, Alvira Dwilestarie; Sari, Rini Mulia; Puspita, Mita; Dewi, Gianita Puspita
免疫/内分泌
SARS-CoV-2
发表日期：2024
文献求助 收藏

Immunogenicity Assessment of the SARS-CoV-2 Protein Subunit Recombinant Vaccine (CoV2-IB 0322) in a Substudy of a Phase 3 Trial in Indonesia

在印度尼西亚开展的一项3期临床试验子研究中，对SARS-CoV-2蛋白亚单位重组疫苗（CoV2-IB 0322）进行了免疫原性评估。

期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines12040371
Shakinah, Sharifah; Aini, Muhammad Hafiz; Sekartini, Rini; Soedjatmiko; Medise, Bernie Endyarni; Gunardi, Hartono; Yuniar, Irene; Indawati, Wahyuni; Koesnoe, Sukamto; Harimurti, Kuntjoro; Maria, Suzy; Wirahmadi, Angga; Sari, Rini Mulia; Setyaningsih, Lilis; Surachman, Fikrianti
免疫/内分泌
SARS-CoV-2
发表日期：2024
文献求助 收藏

Immunogenicity, Safety, and Efficacy of Influenza Vaccine in T2DM and T2DM with Chronic Kidney Disease

流感疫苗在2型糖尿病和合并慢性肾病的2型糖尿病患者中的免疫原性、安全性和有效性

期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines12030227
Heryaman, Henhen; Juli, Cep; Nazir, Arnengsih; Syamsunarno, Mas Rizky A A; Yahaya, Badrul Hisham; Turbawaty, Dewi Kartika; Sari, Rini Mulia; Permana, Hikmat; Supriyadi, Rudi; Atik, Nur
微生物学
糖尿病
免疫/内分泌
流感
代谢
发表日期：2024
文献求助 收藏

A phase II clinical trial of a Vi-DT typhoid conjugate vaccine in healthy Indonesian adolescents and adults: one-month evaluation of safety and immunogenicity

一项针对健康印尼青少年和成人的Vi-DT伤寒结合疫苗的II期临床试验：为期一个月的安全性和免疫原性评估

期刊:Tropical Diseases Travel Medicine and Vaccines
影响因子:2.2
doi:10.1186/s40794-023-00210-z
Koesnoe, Sukamto; Medise, Bernie Endyarni; Rengganis, Iris; Hadinegoro, Sri Rezeki; Puspita, Mita; Sari, Rini Mulia; Yang, Jae Seung; Sahastrabuddhe, Sushant; Soedjatmiko; Gunardi, Hartono; Sekartini, Rini; Wirahmadi, Angga; Kekalih, Aria; Mukhi, Sreshta; Satari, Hindra Irawan; Bachtiar, Novilia Sjafri
免疫/内分泌
发表日期：2024
文献求助 收藏

Immunogenicity and safety of Quadrivalent Influenza HA vaccine compared with Trivalent Influenza HA vaccine and evaluation of Quadrivalent Influenza HA vaccine batch-to-batch consistency in Indonesian children and adults

在印度尼西亚儿童和成人中，比较四价流感HA疫苗与三价流感HA疫苗的免疫原性和安全性，并评估四价流感HA疫苗批间一致性

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0281566
Fadlyana, Eddy; Dhamayanti, Meita; Tarigan, Rodman; Prodjosoewojo, Susantina; Rahmadi, Andri Reza; Sari, Rini Mulia; Rusmil, Kusnandi; Kartasasmita, Cissy B
微生物学
免疫/内分泌
流感
发表日期：2023
文献求助 收藏

Protectivity and safety following recombinant hepatitis B vaccine with different source of bulk compared to hepatitis B (Bio Farma) vaccine in Indonesia

在印度尼西亚，不同原料来源的重组乙肝疫苗与乙肝（Bio Farma）疫苗相比，其保护性和安全性如何？

期刊:Clinical and Experimental Vaccine Research
影响因子:1.3
doi:10.7774/cevr.2022.11.1.43
Nency, Yetty M; Rahmadi, Farid Agung; Mulyono; Anantyo, Dimas Tri; Farhanah, Nur; Hapsari, Rebriarina; Farida, Helmia; Sadhana, Udadi; Djagat, Herry; Kristina, Tri Nur; Juniarto, Achmad Zulfa; Puspita, Mita; Sari, Rini Mulia; Bachtiar, Novilia Sjafri
发表日期：2022
文献求助 收藏

A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2-11 years: a phase II preliminary report

一种新型的白喉类毒素-伤寒结合疫苗安全有效，可在2-11岁健康的印尼儿童中诱导免疫原性：一项II期初步报告

期刊:BMC Pediatrics
影响因子:2
doi:10.1186/s12887-020-02375-4
Medise, Bernie Endyarni; Soedjatmiko, Soedjatmiko; Gunardi, Hartono; Sekartini, Rini; Satari, Hindra Irawan; Hadinegoro, Sri Rezeki; Wirahmadi, Angga; Puspita, Mita; Sari, Rini Mulia; Yang, Jae Seung; Sil, Arijit; Sahastrabuddhe, Sushant; Bachtiar, Novilia Sjafri
免疫/内分泌
发表日期：2020
文献求助 收藏

Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine

一项针对印度尼西亚成人和儿童的随机临床试验（I期研究）的六个月随访结果：伤寒沙门氏菌多糖-白喉类毒素（Vi-DT）结合疫苗的安全性和免疫原性

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0211784
Medise, Bernie Endyarni; Soedjatmiko, Soedjatmiko; Rengganis, Iris; Gunardi, Hartono; Sekartini, Rini; Koesno, Sukamto; Satari, Hindra Irawan; Hadinegoro, Sri Rezeki; Yang, Jae Seung; Excler, Jean-Louis; Sahastrabuddhe, Sushant; Puspita, Mita; Sari, Rini Mulia; Bachtiar, Novilia Sjafri
免疫/内分泌
发表日期：2019
文献求助 收藏